Back to Pathway Library

Cardiovascular

Atrial Fibrillation

Open pathway

The most common arrhythmia diagnosed in clinical practice.

Estimates of the prevalence of Atrial Fibrillation in the United States ranges from about 2.7 million to 6.1 million, while in the Europe Union studies found that 7.6 million people over 65 lived with the condition in 2016 and this will increase by 89% to 14.4 million by 2060.
Atrial Fibrillation doubles the risk of all-cause mortality and impairs quality of life of more than 60% of the patients. About a third of patients had at least one hospitalization episode and 10% had more than 2 hospitalization episodes per year, which corresponds to more than twice when comparing with non-Atrial Fibrillation patients.

Critical Actions

  • Atrial Fibrillation diagnosis;
  • Proper anticoagulant therapy prescription;
  • Paroxysmal Atrial Fibrillation referentiation for ablation procedure.

Phases

  1. 1st Medical consultation
  2. Follow-up consultation
  3. Treatment
  4. Follow-up
  5. Referral
  6. Patient education
  7. Emergency
  8. Inpatient

References

  • Hindricks G., et al. ESC Scientific Document Group, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 373–498
  • January, Craig T., et al. «2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation». Journal of the American College of Cardiology, vol. 74, n. 1, Julho de 2019, pp. 104–32. DOI.org (Crossref), https://doi.org/10.1016/j.jacc.2019.01.011.
  • Arbelo, Elena, et al. «Quality Indicators for the Care and Outcomes of Adults with Atrial Fibrillation». EP Europace, vol. 23, n. 4, Abril de 2021, pp. 494–95. DOI.org (Crossref), https://doi.org/10.1093/europace/euaa253.
  • Writing Committee Members, et al. «2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures». Circulation: Cardiovascular Quality and Outcomes, vol. 14, n. 1, Janeiro de 2021. DOI.org (Crossref), https://doi.org/10.1161/HCQ.0000000000000100.

Browse other pathways

Orthopedic

Coxarthrosis

Cardiovascular

Heart Failure

Pulmonology

COPD

Move towards Patient-Centered care with UpHill

Talk to Sales